CMS seeks feedback on standard info collection—yawn.
Published Date: 9/29/2026
Notice
Summary
The Centers for Medicare & Medicaid Services (CMS) wants your feedback on their plan to collect some new information from the public. This is part of a routine check to make sure the info they gather is useful and not too much work for anyone. If you have thoughts, you’ve got until November 30, 2026, to share them—no cost, just your voice!
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22812, Medicare and Medicaid Programs; Cutting Administrative Requirements for Excellence in Patient Care
CMS is proposing to cut outdated and tricky rules in Medicare and Medicaid to help doctors and nurses spend more time caring for patients instead of paperwork. These changes aim to save money, boost flexibility, and make healthcare better and easier to manage. Comments on this plan are open until January 11, 2027, so everyone affected can share their thoughts!
2026-22750, Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies
Starting in 2027, Medicare is updating how it pays home health agencies, including new payment rates and rules to make care better and fairer. Home health providers, equipment suppliers, and Medicare enrollees will see changes in payment methods, quality reporting, and equipment rules, with some new deadlines and expanded benefits. These updates aim to improve care quality while keeping payments clear and fair.
2026-22792, Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
Starting in 2029, Medicare will negotiate drug prices to help lower costs for people using Medicare Part D. This new rule, effective December 5, 2026, sets clear policies to make prescription drugs more affordable and fair. If you or a loved one uses Medicare for prescriptions, expect some savings and changes in how drug prices are set.
2026-22743, Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Starting January 1, 2027, Medicare and Medicaid are updating how doctors and clinics get paid to better match real medical work and new laws. This includes new rules for drug price rebates, sharing savings programs, and payment updates for rural clinics and ambulance services. These changes affect doctors, patients, and healthcare providers, aiming to keep care fair, affordable, and up-to-date.
2026-22739, Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots
Starting in 2027, Medicare is updating how hospitals and surgery centers get paid for outpatient care and surgeries. These changes affect hospitals, surgery centers, and patients by adjusting payment rates and improving quality reporting. Plus, CMS is asking for ideas to make hospital price info clearer and easier to compare, while also handling rules about emergency care and teaching hospital closures.
2026-22381, Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage
This new rule updates how Organ Procurement Organizations (OPOs) operate to help get more life-saving organs to people who need transplants. It changes some definitions, competition rules, and appeal processes to make OPOs work better and be held accountable. These changes start January 4, 2027, and aim to save more lives without adding extra costs.
Previous / Next Documents
Previous: 2026-19912, FHTA LLC; Withdrawal of Approval of New Drug Application for MYSOLINE (Primidone) Suspension, 250 Milligrams/5 Milliliters
The FDA is officially pulling the approval for MYSOLINE (primidone) suspension, a medicine that hasn’t been sold since 2001 due to safety concerns. FHTA LLC, the company behind it, agreed to this withdrawal without a fight. This means MYSOLINE suspension won’t be coming back unless it’s reformulated and proven safe and effective, so patients and pharmacies should look for other options starting September 29, 2026.
Next: 2026-19914, Methionine From France, Japan, and Spain; Notice of Commission Determination To Conduct Full Five-Year Reviews
The U.S. International Trade Commission is launching full five-year reviews to check if stopping special import taxes on methionine from France, Japan, and Spain would hurt U.S. businesses. This affects companies dealing with methionine imports and could impact prices or trade rules soon. The review schedule will be shared later, so keep an eye out for updates!